CURX
Curanex Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$0.28
+0.01 (+2.99%)
Open$0.28
Previous Close$0.27
Day High$0.29
Day Low$0.26
52W High$29.42
52W Low$14.19
Volume—
Avg Volume165.5K
Market Cap7.82M
P/E Ratio17.32
EPS$1.37
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.70M | 1.62M | 1.35M |
| Net Income | 499.2K | 484.2K | 288.0K |
| Profit Margin | 29.3% | 29.9% | 21.3% |
| EBITDA | 775.5K | 724.0K | 543.0K |
| Free Cash Flow | 289.5K | 292.3K | 286.4K |
| Rev Growth | +22.0% | +2.7% | +4.4% |
| Debt/Equity | 0.23 | 0.19 | 0.17 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |